AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Net Asset Value Aug 14, 2019

4932_rns_2019-08-14_30d6a62b-2726-4d90-b613-a58350ffd53b.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0959J

FTSE Russell

14 August 2019

Further to the FTSE Russell notice released on 12 August 2019 in relation to BTG (UK): Constituent Deletion, please note the FTSE 250 replacement.

All other details remain unchanged. Please see updated notice below:

BTG (UK): Constituent Deletion - Update

Changes in FTSE UK Index Series

14 August 2019

Subject to court sanctioning the scheme of arrangement in relation to the cash acquisition of BTG (UK, constituent) by Bravo Bidco Ltd (non constituent), please see details of affected indexes and effective dates below:

BTG (UK, 0100159) will be deleted from the FTSE 250 Index.

Puretech Health (UK, BY2Z0H7) will be added to the FTSE 250 Index and removed from the FTSE SmallCap Index.

All changes effective from 19 August 2019.

Full details of index changes are available on the FTSE Russell website.

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2019 FTSE Russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FTSEZLFFKVFEBBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.